8.
Comparison of planned and actual chemotherapy treatment groups
| Planned treatment group | Total
[n (%)] |
Actual treatment group [n (%)] | |||
| Docetaxel/anthracycline combo | Docetaxel/anthracycline sequential | Docetaxel/
other |
Other | ||
| Total | 3,020 (100) | 1,421 (47.1) | 447 (14.8) | 705 (23.3) | 447 (14.8) |
| Docetaxel/anthracycline combo | 1,532 (50.7) | 1,395 (46.2) | 28 (0.9) | 18 (0.6) | 91 (3.0) |
| Docetaxel/anthracycline sequential | 477 (15.8) | 9 (0.3) | 414 (13.7) | 2 (0.1) | 52 (1.7) |
| Docetaxel/other | 717 (23.7) | 12 (0.4) | 5 (0.2) | 682 (22.6) | 18 (0.6) |
| Other | 294 (9.7) | 5 (0.2) | 0 (0) | 3 (0.1) | 286 (9.5) |